AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12756407
Drug: Hypertension risk
RxNorm normalized name: INVESTIGATIONAL ANTI-HYPERTENSIVE DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertension risk factors measured including urbanisation, obesity, plasma fibrinogen, lipids, insulin, serum gamma glutamyl‐transferase, dietary intake, smoking and alcohol consumption.
Trial: 10933123
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment plus antibiotics
Trial: 8613045
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection into the lower esophageal sphincter
Trial: 8613045
Drug: Second injection
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second injection of botulinum toxin
Trial: 1350540
Drug: Prostaglandin gel
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin gel induction of labor
Trial: 31450518
Drug: Home-based carer-assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based carer-assisted therapy
Trial: 31450518
Drug: Hospital-based therapist-delivered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital-based therapist-delivered therapy
Trial: 29730659
Drug: Intravenous levothyroxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous levothyroxine treatment
Trial: 20854630
Drug: Candesartan (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (4 to 16 mg once daily for 7 days)
Trial: 17967672
Drug: Conventional catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional catheter group 1 (CC 1)
Trial: 11434650
Drug: Oral arginine
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral arginine (ARG) 9.0 g/d for 9 days, then 18.0 g/d for 9 more days in HD patients
Trial: 11434650
Drug: Oral arginine
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral arginine (ARG) in crossover study
Trial: 11434650
Drug: Oral arginine
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral arginine (ARG)
Trial: 11434650
Drug: Oral arginine
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral arginine (ARG) (+/- CanO)
Trial: 4856938
Drug: 0.5% etidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% etidocaine for bilateral intercostal nerve block (plain solution)
Trial: 30059196
Drug: ALKS 3831
RxNorm normalized name: ALKS 29
DrugBank: ALKS 29 (DB05723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALKS 3831 (10 mg OLZ/10 mg SAM)
Trial: 30059196
Drug: OLZ (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OLZ (10 mg OLZ)
Trial: 30059196
Drug: B-OLZ (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B-OLZ (10 mg B-OLZ)
Trial: 28627861
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (dry land therapy, N=15 patients)
Trial: 21334498
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) intervention on PDAs for 4 weeks
Trial: 14732659
Drug: 20% wt/vol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% wt/vol aminolevulinic acid hydrochloride (ALA) followed by photodynamic therapy (PDT)
Trial: 7923645
Drug: Heparin (5000-U
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (5000-U bolus and 1000-1300-U/h infusion, adjusted to APTT of 60 to 90 seconds)
Trial: 7923645
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy with Hirudin
Trial: 7923645
Drug: Both thrombin
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both thrombin inhibitors
Trial: 2468874
Drug: Nitrendipine 10
RxNorm normalized name: nitrendipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 10 mg b.i.d.
Trial: 2468874
Drug: Hydrochlorothiazide 50
RxNorm normalized name: hydrochlorothiazide 50 MG
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 50 mg q.d.
Trial: 2468874
Drug: Nitrendipine 5‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 5‐20 mg b.i.d.
Trial: 2468874
Drug: Propranolol 40‐120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40‐120 mg b.i.d.
Trial: 23650884
Drug: Grammar treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grammar treatment (experimental group)
Trial: 23650884
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (control group)
Trial: 15138095
Drug: High lactate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High lactate group (lactate > 2 mmol/L)
Trial: 11052960
Drug: Hypoglycemia of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoglycemia of 60 mg/dl
Trial: 11052960
Drug: Hypoglycemia of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoglycemia of 60 and 50 mg/dl
Trial: 8259037
Drug: Recombinant alpha‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant alpha‐2b interferon at 3 MU three times weekly for 3 months, increased to 6 MU for non-responders for an additional 3 months
Trial: 8259037
Drug: Increased dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dosage of interferon to 6 MU for non-responders
Trial: 3936739
Drug: buccal nitroglycerin
RxNorm normalized name: nitroglycerin Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buccal nitroglycerin
Trial: 12870776
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (9 g)
Trial: 3619386
Drug: Urokinase (UK)
DrugBank: Urokinase (DB00013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Urokinase (UK) with heparin (5,000 U IV bolus, followed by 150,000 IU UK IV bolus, then 12,000 IU UK/min for 90 min, total dose 1,230,000 IU)
Trial: 3619386
Drug: Heparin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin alone (5,000 U IV bolus)
Trial: 9586605
Drug: Intravenous anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anesthesia
Trial: 28252528
Drug: Pitavastatin 4
RxNorm normalized name: PITAVASTATIN 4MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin 4 mg daily
Trial: 26780276
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (400 mg) daily for three months
Trial: 24106334
Drug: Clonidine 25
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 25 µg
Trial: 24106334
Drug: Clonidine 150
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 150 µg
Trial: 25231091
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg peramivir
Trial: 15017503
Drug: 0.05 mg
RxNorm normalized name: biotin 0.05 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg clonidine twice a day
Trial: 15017503
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg clonidine twice a day
Trial: 15017503
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg clonidine twice a day
Trial: 10706232
Drug: Daily vitamin‐mineral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily vitamin‐mineral supplementation at 50% of the U.S. daily recommended allowance (RDA) for 3 months
Trial: 8230075
Drug: Salt-sugar solution
RxNorm normalized name: SUGAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salt-sugar solution preparation by mothers
Trial: 8737885
Drug: 25% emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% emulsion of oil of bitter orange (OBO) three times daily
Trial: 8737885
Drug: 20% OBO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% OBO in alcohol three times daily
Trial: 8737885
Drug: Pure OBO,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pure OBO, once daily
Trial: 1389848
Drug: Indomethacin 100
RxNorm normalized name: indomethacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 100 mg i.v. before surgery, followed by 100 mg rectally 6 and 12 h after surgery and at 08:00, 16:00 and 23:00 on the next day
Trial: 22863612
Drug: 4Jointz (3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4Jointz (3.5 g/day, thrice daily)
Trial: 20139789
Drug: Jumping once
RxNorm normalized name: gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Jumping once daily (J1x)
Trial: 17075991
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha (IFN‐alpha) 5 MU daily for 15 days, then three times weekly for six months
Trial: 15589860
Drug: Letrozole (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (7.5 mg daily)
Trial: 15589860
Drug: Clomiphene Citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene Citrate (100 mg daily)
Trial: 8485266
Drug: High-dose ursodeoxycholic
RxNorm normalized name: ursodeoxycholate
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ursodeoxycholic acid (UDCA) (> or = 7 mg.kg/day)
Trial: 8485266
Drug: Low-dose ursodeoxycholic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ursodeoxycholic acid (UDCA) (< 7 mg.kg/day)
Trial: 8485266
Drug: High-dose chenodeoxycholic
RxNorm normalized name: chenodeoxycholate
DrugBank: Chenodeoxycholic acid (DB06777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chenodeoxycholic acid (CDCA) (> or = 10 mg.kg/day)
Trial: 8485266
Drug: Low-dose chenodeoxycholic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose chenodeoxycholic acid (CDCA) (< 10 mg.kg/day)
Trial: 31172979
Drug: Mycobacterium w
RxNorm normalized name: Mycobacterium W Vaccine
DrugBank: Mycobacterium w. Vaccine (DB15798)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mycobacterium w (Mw) vaccine
Trial: 25341548
Drug: 1% topical
RxNorm normalized name: SSD 1% Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% topical sildenafil cream
Trial: 25341548
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream applied to opposite extremity
Trial: 17446014
Drug: Mixed-gender Group
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed-gender Group Drug Counseling (GDC)
Trial: 10192709
Drug: Clarithromycin 2
RxNorm normalized name: clarithromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 2 g/day and Ethambutol 20 mg/kg/day
Trial: 10192709
Drug: Clarithromycin 2
RxNorm normalized name: clarithromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 2 g/day, Ethambutol 20 mg/kg/day, and Clofazimine 200 mg/day
Trial: 7778534
Drug: Enalapril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (2.5 mg twice daily, can be doubled to 10 mg twice daily)
Trial: 2271852
Drug: Antibiotics (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (20 patients)
Trial: 2271852
Drug: No antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotics (20 patients)
Trial: 23246646
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g lactose
Trial: 23246646
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g lactose
Trial: 23246646
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g lactose
Trial: 17319827
Drug: Higher platelet
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher platelet dose (HDP)
Trial: 17319827
Drug: Lower platelet
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower platelet dose (LDP)
Trial: 15067363
Drug: Germinated barley
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Germinated barley foodstuff (GBF) 20 g daily
Trial: 15067363
Drug: Germinated barley
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Germinated barley foodstuff (GBF) with steroid tapering treatment
Trial: 12127385
Drug: Placebo (olive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (olive oil) treatment
Trial: 7981584
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to nucleoli in acute EMS patients
Trial: 7981584
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to nucleoli in chronic EMS patients
Trial: 7981584
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to nucleoli in FS patients
Trial: 7981584
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to 5-HT in FS patients
Trial: 7981584
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to 5-HT in acute EMS patients
Trial: 7981584
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to 5-HT in EMS patients after 2 years
Trial: 7981584
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to Gm1 in acute EMS patients
Trial: 7981584
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to Gm1 in chronic EMS patients
Trial: 7981584
Drug: Antibodies in
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies in healthy controls
Trial: 2547312
Drug: Glucomannan (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucomannan (1 g tid orally)
Trial: 616216
Drug: Finnish sauna
RxNorm normalized name: Sana leaf
DrugBank: Senna leaf (DB15889)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finnish sauna bath with beta-blockade (Oxprenolol 40 mg)
Trial: 31913252
Drug: Beetroot juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot juice (BRJ) 70 ml
Trial: 26518207
Drug: Early responders
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early responders (both treatment arms)
Trial: 22744410
Drug: 4DDOME(®) implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4DDOME(®) implant
Trial: 20507399
Drug: 4-n-butylresorcinol 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-n-butylresorcinol 0.1% cream
Trial: 18779478
Drug: Topical ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketorolac tromethamine, 0.4%
Trial: 15877875
Drug: Aleurone flour
RxNorm normalized name: Flours
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aleurone flour (ALF) - 175 g bread made with ALF and placebo tablet each day
Trial: 20050938
Drug: Sildenafil (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50-100 mg)
Trial: 10710012
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (3.5 mg/kg)
Trial: 11322246
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of saquinavir plus 200 mg of zidovudine
Trial: 11322246
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of saquinavir plus 200 mg of zidovudine
Trial: 31766977
Drug: Crushed Ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Crushed Ticagrelor (CTIC) 180 mg
Trial: 22402329
Drug: Dexamethasone 5
RxNorm normalized name: dexamethasone 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 5 mg for four days
Trial: 17237316
Drug: Fortified dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified dairy product containing eicosapentaenoic acid, docosahexaenoic acid, oleic acid, folic acid, and vitamins A, B‐6, D, and E (500 mL/d)
Trial: 17237316
Drug: Semi‐skimmed milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semi‐skimmed milk with added vitamins A and D (500 mL/d)
Trial: 16784831
Drug: Granisetron hydrochloride
RxNorm normalized name: Granisetron Hydrochloride
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron hydrochloride 1mg rapidly disintegrating tablets
Trial: 16784831
Drug: Granisetron hydrochloride
RxNorm normalized name: Granisetron Hydrochloride
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron hydrochloride 1mg capsules
Trial: 15240527
Drug: Oral CEE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral CEE 0.625 mg/day
Trial: 15240527
Drug: Transdermal E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal E2 50 microg/day
Trial: 15240527
Drug: Fenretinide 100
RxNorm normalized name: FENRETINIDE
DrugBank: Fenretinide (DB05076)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenretinide 100 mg/twice a day
Trial: 15240527
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (both CEE and E2)
Trial: 11074185
Drug: Tiagabine (TGB)
DrugBank: Tiagabine (DB00906)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiagabine (TGB) as add-on therapy
Trial: 11074185
Drug: Phenytoin (PHT)
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin (PHT) as add-on therapy
Trial: 11074185
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) as add-on therapy
Trial: 19517672
Drug: Intravenous piracetam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous piracetam 30 mg kg(‐1)
Trial: 17090953
Drug: L-thyroxine (L-T4)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-thyroxine (L-T4) administration after 2 months of therapy
Trial: 17090953
Drug: L-thyroxine (L-T4)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-thyroxine (L-T4) administration
Trial: 17090953
Drug: No L-thyroxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No L-thyroxine (L-T4) treatment
Trial: 15310558
Drug: Monoamine oxidase
RxNorm normalized name: Monoamine oxidase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoamine oxidase type B inhibitors (MAOBIs)
Trial: 11783838
Drug: Local triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local triamcinolone injection for lateral epicondylitis (<= 12 weeks)
Trial: 11783838
Drug: Intraoperative steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative steroid at discectomy
Trial: 11783838
Drug: Local glycosaminoglycan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local glycosaminoglycan polyphosphate injection for lateral epicondylitis
Trial: 11783838
Drug: Intraarticular steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular steroid injection for shoulder arthritis
Trial: 11783838
Drug: Subacromial steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subacromial steroid injections for rotator cuff tendinitis
Trial: 11783838
Drug: Nonspecific injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonspecific injections for painful shoulder
Trial: 9395805
Drug: Sensitivity of
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensitivity of TRAb compared to anti-thyroglobulin antibodies
Trial: 9395805
Drug: Sensitivity of
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensitivity of TRAb compared to anti-microsomal antibodies
Trial: 9395805
Drug: Specificity of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specificity of TRAb levels > 10.0 U/L
Trial: 7957520
Drug: Transdermal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal dexmedetomidine (625 micrograms applied for 12 h)
Trial: 7957520
Drug: Intravenous dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dexmedetomidine (2.0 micrograms.kg‐1 as dexmedetomidine hydrochloride administered as an infusion over 5 min)
Trial: 7957520
Drug: Transdermal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal dexmedetomidine
Trial: 19583070
Drug: Intravenous dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dexmedetomidine